Skip to main content
Premium Trial:

Request an Annual Quote

uBiome Launches CLIA Lab

NEW YORK (GenomeWeb) – San Francisco-based uBiome today announced the launch of its CLIA laboratory to provide clinical testing based on its microbial assays.

The tests, which evaluate the patient's microbiome for "clinically relevant results," were developed in part with data gathered in a citizen science project, the firm said in a statement.

The firm's mission is "to transform research into useful products based on the microbiome," Co-founder and CEO Jessica Richman said in a statement. "Through our research partnerships with thousands of citizen scientists and dozens of universities, including Harvard, Stanford, and [the University of California, San Francisco], we have gathered millions of data points and built a set of tools that have enabled us to create clinical tests for doctors and patients."

Started by researchers at UCSF, uBiome raised more than $120,000 in crowdfunding to begin its microbiome sequencing project. The firm said that people will still be able to participate in basic research studies of the microbiome and that those tests will be clearly differentiated from clinical tests at the new laboratory.

The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in the European Journal of Human Genetics find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.